S.M.A.R.T. (Students Motivating and Acting in Real-Time) eStudy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 101
- 试验地点
- 2
- 主要终点
- Receipt of the first dose of HPV vaccine in intervention and control group
研究概览
简要总结
This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.
详细描述
PRIMARY OBJECTIVES:
I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability.
II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.
SECONDARY OBJECTIVES:
I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 25 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus
- •Being able to read English
- •Not having received any doses of the HPV vaccine
排除标准
- 未提供
研究组 & 干预措施
Arm I (mHealth HPV vaccine intervention)
Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.
干预措施: Media Intervention (Other)
Arm I (mHealth HPV vaccine intervention)
Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.
干预措施: Survey Administration (Other)
Arm II (standard HPV information and HPV VIS)
Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.
干预措施: Informational Intervention (Other)
Arm II (standard HPV information and HPV VIS)
Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.
干预措施: Survey Administration (Other)
结局指标
主要结局
Receipt of the first dose of HPV vaccine in intervention and control group
时间窗: Up to 7 months
Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.
Participant satisfaction scores
时间窗: Up to 7 months
Acceptability and feasibility will be established by examining participant satisfaction with study materials.
次要结局
未报告次要终点
研究者
Mira Katz
Principal Investigator
Ohio State University Comprehensive Cancer Center